James Baker

Professor of Chemistry University College London

Jamie Baker is a Professor in Chemistry at UCL (2021-current). He previously held posts at UCL as an Associate Professor (2017-2021), Senior Lecturer (2014-2017), Lecturer (2012-2014), an RCUK Research Fellow in Chemical Biology (2007-2012) and PDRA (2005-2007). His research spans the fields of chemical biology, organic synthesis, bioconjugation, ADCs and drug-discovery. This has led to the publication of >80 peer reviewed articles and 2 granted patents. Contributions include pioneering leading reagent classes for antibody conjugation by disulfide re-bridging, including next generation maleimides (NGM) and pyridazinediones (PD). Notably NGM linkers are in a pipeline of ADCs developed by Mabwell (a biopharmaceutical company based in China) currently undergoing advanced clinical trials.

Seminars

Wednesday 10th March 2027
New Insights & Applications of Antibody-Drug Conjugation by Disulfide Re-Bridging
12:15 pm
  • Disulfide re-bridging is a leading method for the construction of next-generation site-selective ADCs, and the resultant ADCs are in advanced clinical trials
  • Sharing a detailed understanding of the processes involved in re-bridging has been lacking to date, and has led to difficulty in identifying optimal reagents and protocols to maximise homogeneity
  • Revealing recent data which shines a new light on these conjugates, provides new design principles for optimised conjugates, whilst also discussing new ADC opportunities enabled by disulfide re-bridging strategies
Jamie Baker - UCL